SPYRE THERAPEUTICS INC

Ticker: SYRE CUSIP: 00773J202 Class: Common Stock

Candriam S.C.A.'s Holding History (CIK: 0001537014)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 425,534 Value ($000) $13,941 Avg Close $26.13 Range $15.86 - $35.31
Q3 2025
Shares 404,362 Value ($000) $6,777 Avg Close $16.31 Range $14.00 - $18.30
Q2 2025
Shares 246,030 Value ($000) $3,683 Avg Close $14.80 Range $10.91 - $19.20
Q1 2025
Shares 246,030 Value ($000) $3,970 Avg Close $20.81 Range $16.13 - $26.01
Q4 2024
Shares 247,591 Value ($000) $5,764 Avg Close $29.32 Range $22.37 - $40.26
Q3 2024
Shares 105,000 Value ($000) $3,088 Avg Close $27.85 Range $23.00 - $32.41
Q2 2024
Shares 105,000 Value ($000) $2,468 Avg Close $33.73 Range $22.19 - $40.84
Q1 2024
Shares 105,000 Value ($000) $3,983 Avg Close $28.97 Range $18.54 - $47.97